Point72 Asset Management
ABBV icon

Point72 Asset Management’s AbbVie ABBV Stock Holding History

Point72 Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-359,444
Closed -$81.9M – 3867
2025
Q3 		$83.2M Buy
359,444
+354,234
+6,799% +$72.1M 0.14% 158
2025
Q2 		$967K Buy
+5,210
New +$968K ﹤0.01% 1573
2024
Q2 		– Sell
-42,138
Closed -$7.67M – 1792
2024
Q1 		$7.67M Sell
42,138
-745,362
-95% -$128M 0.02% 821
2023
Q4 		$122M Sell
787,500
-234,374
-23% -$34.2M 0.3% 62
2023
Q3 		$152M Buy
1,021,874
+400,875
+65% +$58.8M 0.44% 31
2023
Q2 		$83.7M Sell
620,999
-407,901
-40% -$59.8M 0.25% 102
2023
Q1 		$164M Buy
+1,028,900
New +$157M 0.51% 30
2021
Q1 		– Sell
-54,446
Closed -$5.82M – 929
2020
Q4 		$5.83M Sell
54,446
-32,955
-38% -$3.17M 0.03% 555
2020
Q3 		$7.66M Sell
87,401
-160,627
-65% -$15.1M 0.04% 468
2020
Q2 		$24.4M Sell
248,028
-1,142,878
-82% -$101M 0.16% 182
2020
Q1 		$106M Buy
+1,390,906
New +$118M 0.86% 17
2019
Q3 		– Sell
-884,906
Closed -$64.3M – 1092
2019
Q2 		$64.3M Buy
884,906
+814,776
+1,162% +$64M 0.34% 70
2019
Q1 		$5.65M Buy
+70,130
New +$5.74M 0.03% 536
2017
Q3 		– Sell
-170,000
Closed -$12.3M – 849
2017
Q2 		$12.3M Sell
170,000
-770,300
-82% -$51.8M 0.07% 347
2017
Q1 		$61.3M Sell
940,300
-196,266
-17% -$12.3M 0.34% 67
2016
Q4 		$71.2M Buy
+1,136,566
New +$69.4M 0.5% 39
2015
Q3 		– Sell
-1,245,500
Closed -$83.7M – 745
2015
Q2 		$83.7M Buy
1,245,500
+1,100,700
+760% +$71.9M 0.58% 36
2015
Q1 		$8.48M Buy
+144,800
New +$8.75M 0.06% 356
2014
Q4 		– Sell
-184,300
Closed -$10.6M – 644
2014
Q3 		$10.6M Buy
+184,300
New +$10.2M 0.08% 277

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management's ABBV Position: Q4 2025 in Review

Point72 Asset Management sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 359,444 shares — an estimated $81.9M sold.

Point72 Asset Management first reported a position in ABBV in Q3 2014 and held it in 19 quarters. The position peaked at $164M in Q1 2023. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Point72 Asset Management reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Point72 Asset Management sold 359,444 AbbVie shares in Q4 2025, an estimated $81.9M.
  • Point72 Asset Management first reported a position in AbbVie in Q3 2014 and held it in 19 quarters.
  • Point72 Asset Management's AbbVie position peaked at $164M in Q1 2023.
  • 4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.